Literature DB >> 27566658

Enhancement of Pathologist's Routine Practice: Reuse of DNA Extracted from Immunostained Formalin-fixed Paraffin-embedded (FFPE) Slides in Downstream Molecular Analysis of Cancer.

Asmaa Al-Attas1, Mourad Assidi2, Jaudah Al-Maghrabi3, Ashraf Dallol2, Hans-Juergen Schulten1, Muhammad Abu-Elmagd1, Adeel Chaudhary1, Adel Abuzenadah2, Bruce Budowle4, Abdelbaset Buhmeida5, Mohammed Al-Qahtani1.   

Abstract

BACKGROUND/AIM: To date, the conventional formalin-fixed, paraffin-embedded (FFPE) technique is the gold-standard for preserving histomorphology. Once FFPE tissues are stained, slides are routinely archived along with their blocks at biobanks/hospitals. However, the reuse of fixed and stained biospecimens as DNA source is not a common routine practice worldwide and, thus, indicates the need of studies to investigate the feasibility of extracting DNA from already immunohistochemistry (IHC) FFPE-stained slides and its possible reuse in subsequent downstream molecular analyses.
MATERIALS AND METHODS: FFPE IHC slides from colorectal cancer (CRC) patients were prepared and stored in the CEGMR Biobank. The workflow consists of digitalization of IHC stained slide's image, removing the slide cover-slip, crude dissection and DNA extraction. Following DNA quality assessment, mutation analysis of CTNNB1 and methylation profile of CDH1 were performed.
RESULTS: High-quality DNA was obtained allowing 60% concordance between CDH1 methylation and membranous E-cadherin expression pattern. Clean CTNNB1 DNA chromatograms with evenly-spaced peaks were observed.
CONCLUSION: This study is a proof of concept to recycle and reuse DNA from IHC stained slides with suitable concentration and integrity for further downstream molecular applications. These findings will enhance the pathologists' knowledge, attitudes and practices (KAP) towards the use of these biospecimens and support the implementation of this approach in clinical pathology practice. Therefore, the scientific community will benefit from the largest comprehensive database of human fully annotated FFPE biospecimens already available at their disposal in order to demystify the complexity and the heterogeneity of many challenging diseases and foster the transition towards precision medicine. Copyright
© 2016, International Institute of Anticancer Research (Dr. John G. Delinasios), All rights reserved.

Entities:  

Keywords:  DNA reuse; FFPE; IHC; methylation; mutation analysis; slide image digitalization

Mesh:

Substances:

Year:  2016        PMID: 27566658      PMCID: PMC5070629     

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  45 in total

1.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

2.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

3.  Role of CDH1 promoter methylation in colorectal carcinogenesis: a meta-analysis.

Authors:  Yu-Xi Li; Yao Lu; Chun-Yu Li; Peng Yuan; Shu-Sen Lin
Journal:  DNA Cell Biol       Date:  2014-03-31       Impact factor: 3.311

4.  Beta-catenin mutations in cell lines established from human colorectal cancers.

Authors:  M Ilyas; I P Tomlinson; A Rowan; M Pignatelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  RASSF1A methylation is predictive of poor prognosis in female breast cancer in a background of overall low methylation frequency.

Authors:  Abdelbaset Buhmeida; Adnan Merdad; Judah Al-Maghrabi; Joudah El-Maghrabi; Fatima Al-Thobaiti; Manar Ata; Ayman Bugis; Kari Syrjänen; Adel Abuzenadah; Adeel Chaudhary; Mamdooh Gari; Mohammed Al-Qahtani; Ashraf Dallol
Journal:  Anticancer Res       Date:  2011-09       Impact factor: 2.480

6.  Hypermethylation of the promoter region of the E-cadherin gene (CDH1) in sporadic and ulcerative colitis associated colorectal cancer.

Authors:  J M Wheeler; H C Kim; J A Efstathiou; M Ilyas; N J Mortensen; W F Bodmer
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

7.  Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.

Authors:  Teppei Morikawa; Aya Kuchiba; Mai Yamauchi; Jeffrey A Meyerhardt; Kaori Shima; Katsuhiko Nosho; Andrew T Chan; Edward Giovannucci; Charles S Fuchs; Shuji Ogino
Journal:  JAMA       Date:  2011-04-27       Impact factor: 56.272

8.  Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.

Authors:  Adnan Merdad; Sajjad Karim; Hans-Juergen Schulten; Ashraf Dallol; Abdelbaset Buhmeida; Fatima Al-Thubaity; Mamdooh A Gari; Adeel Ga Chaudhary; Adel M Abuzenadah; Mohammed H Al-Qahtani
Journal:  Anticancer Res       Date:  2014-03       Impact factor: 2.480

9.  Histological assessment of PAXgene tissue fixation and stabilization reagents.

Authors:  Marcel Kap; Frank Smedts; Wolter Oosterhuis; Rosa Winther; Nanna Christensen; Bilge Reischauer; Christian Viertler; Daniel Groelz; Karl-Friedrich Becker; Kurt Zatloukal; Rupert Langer; Julia Slotta-Huspenina; Koppany Bodo; Bas de Jong; Uwe Oelmuller; Peter Riegman
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

Review 10.  The revolution in human monogenic disease mapping.

Authors:  Emma Duncan; Matthew Brown; Eileen M Shore
Journal:  Genes (Basel)       Date:  2014-09-05       Impact factor: 4.096

View more
  3 in total

1.  Formalin-Fixed Paraffin-Embedded (FFPE) samples are not a beneficial replacement for frozen tissues in fetal membrane microbiota research.

Authors:  Rochelle Hockney; Caroline H Orr; Gareth J Waring; Inge Christiaens; Gillian Taylor; Stephen P Cummings; Stephen C Robson; Andrew Nelson
Journal:  PLoS One       Date:  2022-03-17       Impact factor: 3.240

2.  Early Molecular Stratification of High-risk Primary Biliary Cholangitis.

Authors:  Claire Hardie; Kile Green; Laura Jopson; Ben Millar; Barbara Innes; Sarah Pagan; Dina Tiniakos; Jessica Dyson; Muzlifah Haniffa; Venetia Bigley; David E Jones; John Brain; Lucy J Walker
Journal:  EBioMedicine       Date:  2016-11-21       Impact factor: 8.143

3.  The development of a Biobank of cancer tissue samples from World Trade Center responders.

Authors:  Wil Lieberman-Cribbin; Stephanie Tuminello; Christina Gillezeau; Maaike van Gerwen; Rachel Brody; Michael Donovan; Emanuela Taioli
Journal:  J Transl Med       Date:  2018-10-11       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.